North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
Public ClinicalTrials.gov record NCT03548779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03548779
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Enrollment
- 548 participants
Conditions and interventions
Conditions
- Autism Spectrum Disorder
- Brain Malformation
- Chromosome Abnormality
- Congenital Abnormality
- Development Delay
- Dysmorphic Features
- Epilepsy; Seizure
- Genetic Disease
- Hearing Loss
- Hypotonia
- Inborn Errors of Metabolism
- Intellectual Disability
- Macrocephaly
- Microcephaly
- Movement Disorders
- Neuromuscular Diseases
- Skeletal Dysplasia
Interventions
- Pre-visit prep Behavioral
- usual care + exome seq Diagnostic Test
Behavioral · Diagnostic Test
Eligibility (public fields only)
- Age range
- 0 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 27, 2018
- Primary completion
- Sep 7, 2023
- Completion
- Sep 7, 2024
- Last update posted
- May 12, 2025
2018 – 2024
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mission Health | Asheville | North Carolina | 28801 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| East Carolina University | Greenville | North Carolina | 27858 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03548779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03548779 live on ClinicalTrials.gov.